［1］Reisenbuckler C.Multiple myeloma and diagnostic imaging［J］.Radiol Technol，2014，85(4)：391-410.
［2］ZHANG L，CHEN LM.Application of blood purification in renal impairment of multiple myeloma［J］.Basic Medical Sciences and Clinics，2018，38(1)：112-117.［张磊，陈丽萌.血液净化治疗多发性骨髓瘤肾脏损害［J］.基础医学与临床，2018，38(1)：112-117.］
［3］WU WZ，ZHOU ZG，CHEN YF，et al.Research progress on pathogenesis and treatment of anemia in multiple myeloma［J］.World Clinical Drugs，2016，37(8)：572-576.［吴文忠，周志刚，陈亚峰，等.多发性骨髓瘤贫血的发病机制及治疗研究进展［J］.世界临床药物，2016，37(8)：572-576.］
［4］Prabhala RH，Pelluru D，Fulciniti M，et al.Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma［J］.Blood，2010，115(26)：5385-5392.
［5］ZHANG X，JU SQ.Research progress of microRNA and multiple myeloma［J］.Chinese Journal of Clinical Laboratory Science，2011，29(7)：513-515.［张霞，鞠少卿.microRNA与多发性骨髓瘤的研究进展［J］.临床检验杂志，2011，29(7)：513-515.］
［6］ZHAO CM，LI WQ，FENG JM，et al.The development of MicroRNA and the chemoresistance of multiple myeloma［J］.International Journal of Immunology，2017，40(5)：557-560.［赵长明，李文倩，冯建明，等.MicroRNA与多发性骨髓瘤化疗耐药的研究进展［J］.国际免疫学杂志，2017，40(5)：557-560.］
［7］Misiewiczkrzeminska I，Sarasquete ME，Quwaider D，et al.Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of p53 and inhibition of DNA replication［J］.Haematologica，2013，98(4)：640-648.
［8］Belmar J，Fesik SW.Small molecule Mcl-1 inhibitors for the treatment of cancer［J］.Pharmacol Ther，2015(145)：76-84.
［9］Doi K，Gowda K，Liu Q，et al.Pyoluteorin derivatives induce Mcl-1 degradation and apoptosis in hematological cancer cells［J］.Cancer Bio Ther，2014，15(12)：1688-1699.
［10］Liu X，Tang H，Chen J，et al.MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer［J］.Oncotarget，2015，6(24)：20070-20083.
［11］Rocci A，Hofmeister CC，Geyer S，et al.Circulating miRNA markers show promise as new prognosticators for multiple myeloma［J］.Leukemia，2014，28(9)：1922-1926.
［12］Hao M，Zang M，Zhao L，et al.Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis［J］.Oncotarget，2016，7(15)：19589-19600.
［13］Michels J，Johnson PW，Packham G.Mcl-1［J］.Int J Biochem Cell Biol，2005，37(2)：267-271.
［14］Fernándezmarrero Y，Spinner S，Kaufmann T，et al.Survival control of malignant lymphocytes by anti-apoptotic MCL-1［J］.Leukemia，2016，30(11)：2152-2159.
［15］Konno Y，Dong P，Xiong Y，et al.MicroRNA-101 targets EZH2，MCL-1 and FOS to suppress proliferation，invasion and stem cell-like phenotype of aggressive endometrial cancer cells［J］.Eur J Cancer，2014，5(15)：6049-6062.
［16］ WANG MC，ZHANG B.Molecular mechanism of myeloid cell leukemia-1 for multiple myeloma［J］.Journal of Xi'an Jiaotong University，2011，32(4)：429-432.［王孟昌，张斌.髓样细胞白血病-1基因在多发性骨髓瘤发病中的分子机制［J］.西安交通大学学报(医学版)，2011，32(4)：429-432.］
［17］Alqudah MAY，Mansour HT，Mhaidat N.Simvastatin enhances irinotecan-induced apoptosis in prostate cancer via inhibition of MCL-1［J］.Saudi Pharmaceutical Journal，2017，26(2)：191-197.
［18］JI XX，LIU F，XIA H，et al.Downregulation of MCL-1 by diallyl disulfide induces G2/M arrest in human leukemia K562 cells and its mechanism［J］.Journal of Experimental Hematology，2018，26(3)：750-755.［吉晓霞，刘芳，夏红，等.二烯丙基二硫下调MCL-1诱导K562细胞G2/M阻滞及其机制［J］.中国实验血液学杂志，2018，26(3)：750-755.］
［19］YANG X，WANG R，XU K，et al.Knockdown of myeloid cell leukemia 1 gene inhibits the proliferation and promotes apoptosis of prostate cancer cells［J］.Journal of Cellular and Molecular Immunology，2017，33(1)：62-66.［杨侠，王瑞，徐凯，等.敲低髓细胞白血病基因1(MCL-1)促进前列腺癌细胞的增殖并促进其凋亡［J］.细胞与分子免疫学杂志，2017，33(1)：62-66.］
［20］Chautard E，Goumy C，Vago P，et al.Strong correlation between and MCL-1 mRNA expression levels in B-cell chronic lymphocytic leukemia［J］.Leuk Res，2009，33(12)：1623-1626.
［21］ZHANG J，LV XM，YANG YH，et al.Expression of MCL-1 protein in colon cancer and its relationship with drug resistance related proteins GST-PI and P-gp［J］.Guangdong Medical Journal，2016，37(8)：1194-1196.［赵静，吕小梅，杨玉华，等.MCL-1蛋白在结肠癌中的表达及与耐药相关蛋白GST-π、P-gp的关系［J］.广东医学，2016，37(8)：1194-1196.］
［22］SONG L，LI Y，SUN YX，et al.IL-6 inhibits apoptosis of human myeloma cell line XG-7 through activation of JAK/STAT pathway and up-regulation of mcl-1［J］.Chinese Journal of Cancer，2002，21(2)：113-116.［宋伦，黎燕，孙英勋，等.JAK/STAT信号转导途径活化和Mcl-1表达上调介导IL-6在人骨髓瘤细胞系XG-7上的凋亡抑制效应［J］.中国肿瘤，2002，21(2)：113-116.］
［23］Wang M，Wu D，Liu P，et al.Silence of MCL-1 upstream signaling by shRNA abrogates multiple myeloma growth［J］.Exp Hematol Oncol，2014，3(1)：1-7.